QLT Inc.
QLT restructures Visudyne(R) agreement
Published in Physician Law Weekly, November 4th, 2009
QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") announced that it has restructured its agreement with Novartis Pharma AG ("Novartis") to simplify the relationship, under which, effective January 1, 2010, it will, among other things, receive exclusive U.S. rights to the Visudyne® patents to sell and market Visudyne in the U.S. Visudyne, a photosensitizer co-developed with Novartis, is approved worldwide for the treatment of a form of wet age-related macular degeneration ("AMD"), the leading cause of legal blindness in people over the age of 55 in North America and Europe.
Under the Amended and Restated PDT Product Development, Manufacturing and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
Source: Physician Law Weekly (2009-11-04)
More Articles from Physician Law Weekly
- Agency for Healthcare Research & Quality
Patient Safety and Medical Liability Reform Subcommittee Meeting - AIDS Healthcare Foundation
Congress Enacts AIDS Bill to Test 5 Million; AHF Urges President Obama to Act Swiftly - American Scientific Resources, Inc.
American Scientific Resources Announces Addition of New Board Member - American Society for Investigative Pathology
APC Supports SACGHS' landmark recommendations on DNA patenting exempting caregivers - Anxiety Disorders
Studies from University of Sao Paulo provide new data on anxiety disorders - Arizona Medical Marijuana Policy Project
Arizona Medical Marijuana Policy Project, Sponsors of 2010 Medical Marijuana Ballot Initiative in Arizona, Cheer Obama Administration Action - More from this issue of Physician Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
